Exelixis (EXEL) Current Assets (2010 - 2026)
Exelixis (EXEL) recorded quarterly Current Assets of $1.2 billion in Q2 2026, down 16.26% quarter-over-quarter from $1.4 billion in Q1 2026, and down 13.45% on a YoY basis from $1.4 billion in Q2 2025.
Exelixis (EXEL) Current Assets (2010 - 2026) Analysis & Trends
Exelixis' Current Assets history runs 17 years deep, the most recent figure standing at $1.2 billion for Q2 2026.
- In Q2 2026, Current Assets fell 13.45% year-over-year to $1.2 billion; the TTM figure through Apr 2026 stood at $1.2 billion (down 13.45% YoY), while the FY2026 annual figure was $1.4 billion, down 1.66% from the prior year.
- Current Assets was $1.2 billion for Q2 2026 at Exelixis, down from $1.4 billion in the prior quarter.
- In the past five years, Current Assets ranged from a high of $1.9 billion in Q3 2022 to a low of $1.2 billion in Q3 2025.
- Historically, Current Assets has averaged $1.5 billion across 5 years, with a median of $1.5 billion in 2025.
- The sharpest annual moves came in 2022 and 2023: Current Assets gained 28.48% in 2022, then fell 21.63% in 2023.
- A 5-year view of Current Assets shows it stood at $1.6 billion in 2022, then declined by 18.58% to $1.3 billion in 2023, then rose by 17.58% to $1.5 billion in 2024, then fell by 9.52% to $1.4 billion in 2025, then slipped by 13.81% to $1.2 billion in 2026.
- The last three Current Assets figures came in at $1.2 billion (Q2 2026), $1.4 billion (Q1 2026), and $1.4 billion (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 3.59 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 600.85 Mn |
| 10 | Exelixis | 13.37 Bn | 12.59 Bn | 590.86 Mn | 1.21 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 1.21 Bn |
| Jan 2, 2026 | 1.44 Bn |
| Oct 3, 2025 | 1.40 Bn |
| Jul 4, 2025 | 1.18 Bn |
| Apr 4, 2025 | 1.40 Bn |
| Jan 3, 2025 | 1.47 Bn |
| Sep 27, 2024 | 1.55 Bn |
| Jun 28, 2024 | 1.48 Bn |
| Mar 29, 2024 | 1.29 Bn |
| Dec 29, 2023 | 1.32 Bn |
| Sep 29, 2023 | 1.44 Bn |
| Jun 30, 2023 | 1.59 Bn |
| Mar 31, 2023 | 1.64 Bn |
| Dec 30, 2022 | 1.62 Bn |
| Sep 30, 2022 | 1.84 Bn |
| Jul 1, 2022 | 1.85 Bn |
| Apr 1, 2022 | 1.84 Bn |
| Dec 31, 2021 | 1.83 Bn |
| Oct 1, 2021 | 1.66 Bn |
| Jul 2, 2021 | 1.59 Bn |